What OGNA LAB S.r.l. does

OGNA LAB S.r.l. — operating under the legal name GIOVANNI OGNA E FIGLI S.r.l. — is an Italian dental pharmaceutical manufacturer founded in 1960, headquartered in Muggiò (province of Monza-Brianza), with a customer-facing contact office in Milan (Via Morozzo della Rocca, 3). The company develops, manufactures, and commercializes professional dental pharmaceutical and medical-device products organized into seven product lines: anesthesia (injectable and surface anesthetics), endodontics (canal irrigation, traditional and retrograde sealers, retreatments, endodontic repairs), disinfection (instruments, sterilization, surfaces, hand hygiene), surgery (hemostatic products), conservative/restorative dentistry, hygiene and prophylaxis (prophylaxis pastes and scaling products), and prosthetics (impression materials and gingival retraction solutions). Named formulations include ALUCHLOR (25% aluminium chloride astringent), ASTAL SOLUTION (20% ferric sulfate, epinephrine-free), GENGISTAL (25% aluminium sulfate), ROSOL effervescent oral-rinsing tablets, DEPURDENT PROFESSIONAL fluoride-free prophylaxis paste, and DETARZIN scaling paste (RDA 150, zirconium silicate). Differentiation rests on domain specialization for dental use cases — specific chemistries (EDTA 17% chelation, controlled-abrasivity polishing pastes, epinephrine-free astringents) — rather than novel platform technology; there are no disclosed patents, proprietary algorithms, or AI/ML components.

OGNA operates a B2B direct sales model targeting licensed dental professionals — dentists, dental hygienists, dental technicians, and dental assistants. The corporate website enforces a credential-gating model that requires visitors to declare their professional status before accessing content, which signals a controlled professional distribution channel rather than mass retail. Revenue is generated entirely through product sales (a single hardware-sales stream for dental pharmaceutical and medical-device products); pricing is not publicly disclosed. Marketing reach comprises a bilingual (Italian/English) professional website with downloadable technical product sheets and direct participation in Italian dental congresses, including the AIE — Focus on Biomaterials and the 39° SIE National Congress 2024. Distribution is described as regional across Europe.

The company is privately held and family-owned (the legal name "E FIGLI" — meaning "and sons" in Italian — indicates generational succession). The input discloses no institutional investors, no public listing, no M&A, leadership changes, patents, awards, or management team data, and no revenue, headcount growth, or financial performance metrics.

Name

OGNA LAB S.r.l.

Legal name

GIOVANNI OGNA E FIGLI S.r.l.

Website

https://ognalaboratori.it

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

11–50 employees

Short description

OGNA LAB S.r.l. is an Italian dental pharmaceutical manufacturer (founded 1960, family-owned GIOVANNI OGNA E FIGLI) that produces and sells seven professional dental product lines — anesthesia, endodontics, disinfection, surgery, conservative, hygiene/prophylaxis, and prosthetics — directly to licensed dental practitioners across Europe.

Ownership category

akta.pro rank

Product category

Dental Pharmaceutical Products

NAICS

Dental Equipment and Supplies Manufacturing (339114)

SIC

Dental Equipment & Supplies (3843)

akta.pro primary industry

Crown & Bridge (Fixed Prosthetics) Fabrication (HLABAJAA)

akta.pro secondary industries

Implant Prosthetics & Abutment Fabrication (HLABAJAC), Dentoalveolar Surgery (Tooth Extractions & Alveoloplasty) (HLABAEAA)

Keywords

• Dental pharmaceuticals
• Endodontic materials
• Dental anesthetics
• Prophylaxis products
• Dental surgical supplies

Headquarters

HQ city

Muggiò

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Dental Pharmaceutical Products: Sale of professional dental products including anesthetics, endodontic materials, disinfection products, surgical materials, and prosthetic supplies to dental practices and professionals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

OGNA LAB S.r.l. manufactures and commercializes pharmaceutical and medical device products for dental practices, spanning local anesthetics, endodontic sealers and irrigation solutions, disinfection products, hemostatic agents, prophylaxis pastes, surgical materials, conservative dentistry supplies, and prosthetic/impression materials. The company sells these professional-grade products exclusively to licensed dental practitioners through B2B channels.

Product overview

OGNA LAB S.r.l. is an Italian dental pharmaceutical company offering a comprehensive portfolio of dental products organized into seven distinct product lines: LINEA ANESTESIA (injectable and surface anesthetics for pain control), LINEA ENDODONZIA (endodontic treatments including canal irrigation, sealers, retreatments, and repairs), LINEA DISINFEZIONE (disinfection and sterilisation products for instruments, surfaces, and hands), LINEA CHIRURGIA (hemostatic products), LINEA CONSERVATIVA (restorative treatments and cavity liners), LINEA IGIENE E PROFILASSI (prophylaxis pastes and scaling products), and LINEA PROTESICA (impression materials and gingival retraction solutions). Specific named products include ALUCHLOR, ASTAL SOLUTION, GENGISTAL, ROSOL, DEPURDENT PROFESSIONAL, and DETARZIN. The company focuses on safety and innovation in dentistry, serving dental professionals with pharmaceutical-grade products.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• VOCO: German dental materials manufacturer focused on restoratives, endodontics, and preventive products. Highly comparable as a mid-sized specialized dental materials manufacturer serving dental professionals across multiple product categories.
• Pierrel: Italian-headquartered pharmaceutical CDMO with dental anesthetic manufacturing operations. Particularly relevant as a domestic Italian peer in the dental pharmaceutical niche with overlapping injectable anesthetic product lines.
• Ultradent Products: US-based dental materials manufacturer specializing in endodontics, restorative dentistry, and prophylaxis products. Compares as a focused dental pharmaceutical/materials manufacturer with similar product categories and professional distribution model.
• Coltène: Swiss dental materials manufacturer focused on endodontics, restorative dentistry, and prosthetics. Comparable mid-sized specialty dental manufacturer with similar product mix and professional distribution model.
• DMG (Dental Materials Group): German-based dental manufacturer offering restoratives, endodontic sealers, and prosthetic materials. Similar to OGNA as a specialized mid-market dental materials manufacturer with comparable product mix.
• Septodont: French-headquartered global leader in dental anesthetics and pharmaceutical products. Directly comparable as a specialized dental pharmaceutical manufacturer serving dental professionals with injectable anesthetics, endodontic materials, and clinical supplies — overlapping directly with OGNA's core categories.

Emerging players

• Detax: German specialty manufacturer of dental materials including impression materials, prosthetic supplies, and endodontic products. Comparable as a smaller specialty dental manufacturer with overlapping product categories serving European dental professionals.

Broad incumbents

• Ivoclar Vivadent: Liechtenstein-based global dental products manufacturer with strong presence in restorative materials, prosthetics, and endodontics. Overlaps with OGNA's prosthetic/impression, conservative, and endodontic lines.
• Dentsply Sirona: Largest global dental equipment and materials manufacturer, offering endodontic sealers, anesthetics, and consumables across all dental clinical categories. A broad incumbent whose endodontic and consumables lines directly overlap OGNA's portfolio.
• Kerr Dental (Envista Holdings): US-based dental consumables and equipment brand under Envista Holdings. Offers endodontic sealers, restorative materials, and impression products that directly compete with OGNA's core categories at much larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/giovanni-ogna-e-figli-srl

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OGNA LAB S.r.l.